Kestra Medical Technologies, Ltd. (KMTS) Reports Q2 Loss of $2.21

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q2 EPS of ($2.21). Revenue for the quarter came in at $17.2 million.

For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.

You May Also Be Interested In

• Citi downgrades Abercrombie & Fitch to neutral after 36% stock surge
• Veeva Systems (VEEV) Tops Q2 EPS by 13c; Offers Guidance
• Inhibrx Biosciences (INBX) Reiterated at Market Perform by Citizens as Ozekibart Ph1 Started